Eunice Fitas
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Real-World Outcomes across Baseline Risk Profiles in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights from the ORESTES Study.
Journal: Pulmonary therapy
Published: March 26, 2026
Shaping the Future of Evidence Generation: Real-World Data to Drive Healthcare Transformation and Patient-Centered Decisions.
Journal: Pharmaceutical medicine
Published: December 14, 2025
Towards more effective, efficient, and person-centered care for patients with chronic conditions in Spain through the CARABELA initiative.
Journal: Journal of healthcare quality research
Published: December 11, 2025
Response to: Letter to the Editor Regarding 'Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dehydrate in Spain: ORESTES Study'.
Journal: Advances in therapy
Published: December 08, 2025
Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate After Dual and Triple Therapy in Spain: A Sub-Study of the ORESTES Study.
Journal: Pulmonary therapy
Published: November 26, 2025
Integrating the patient's voice in Primary Care for chronic diseases in CARABELA-PC
Journal: Semergen
Published: November 04, 2025
Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dehydrate in Spain: ORESTES Study.
Journal: Advances in therapy
Published: August 06, 2025
Enhancing the management of chronic diseases in clinical practice: The CARABELA methodology.
Journal: Journal of healthcare quality research
Published: May 15, 2024
Geographical differences in the use of oral corticosteroids in patients with severe asthma in Spain: heat map based on existing databases analyses.
Journal: BMC pulmonary medicine
Published: March 04, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026